Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized single-blind study of remimazolam for general anesthesia in adult cardiac surgery
2013-001113-32Phase 2Completed
- Sponsor
- PAION AG
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of remimazolam in None (2 arms), sponsored by PAION AG. Primary endpoint: Successful anesthesia without rescue sedative. Started Apr 2013; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on 2013-001113-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001113-32.